HUTCHMED (China) Limited (HCM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$15.16
+6.76%
Mkt Cap $2.49B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$15.37
Range $13.60 – $18.50
Implied Upside
+1.4%
Consensus $15.37 vs current $15.16